1. Beneficial factors in the therapeutic strategy following initial endocrine therapy for first distant recurrence of breast cancer in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative cancer. (April 2018) Authors: Yamamura, J.; Kamigaki, S.; Tsujie, M.; Fujita, J.; Osato, H.; Komoike, Y. Journal: European journal of cancer Issue: Volume 92(2018)Supplement 3 Page Start: S115 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗